Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CVS Health Lowers FY2025 GAAP EPS Guidance from $3.84-$3.94 to $(0.34)-$(0.24) vs $3.96 Est

Author: Benzinga Newsdesk | October 29, 2025 05:37am
CVS Health (NYSE:CVS) lowers FY2025 GAAP EPS guidance from $3.84-$3.94 to $(0.34)-$(0.24) vs $3.96 analyst estimate..

Posted In: CVS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist